Antibody-mediated rejection: an evolving entity in heart transplantation

Area of Science:

• Transplantation immunology
• Cardiovascular research
• Immunopathology

Background:

• Antibody-mediated rejection (AMR) is a significant complication following heart transplantation.
• It leads to allograft failure, cardiac allograft vasculopathy, and reduced patient survival.
• AMR involves donor-specific antibodies (DSA) activating the complement system, causing myocardial injury.

Purpose of the Study:

• To review the evolving understanding of AMR in heart transplantation.
• To highlight advancements in diagnosis and treatment strategies.
• To identify areas requiring further research.

Main Methods:

• Literature review of AMR pathogenesis, diagnosis, and treatment.
• Analysis of diagnostic shifts from clinical to pathological criteria.
• Evaluation of emerging therapeutic agents targeting the humoral immune system.

Main Results:

• AMR diagnosis has transitioned to a pathology-based approach.
• Treatment strategies are multifaceted, targeting humoral immunity.
• Proteasome and complement inhibitors show promise in managing AMR.

Conclusions:

• Significant progress has been made in understanding AMR.
• Further research is needed for optimal diagnostic tools and treatments.
• Refining therapeutic timing and agents is crucial for improving outcomes.